Gastrointestinal Market Research Reports & Industry Analysis
While many of these illnesses are chronic and can only be treated medically, more holistic and natural approaches are being used more frequently to prevent and manage gastrointestinal disorders. Many healthcare providers are recommending stress management, a healthy diet, and exercise to prevent and manage symptoms.
Exercise has shown to decrease the risk of colon cancer, minimize constipation and improve overall GI health. Even minimal exercise paired with a healthy diet of fruits, vegetables, low fat protein and avoidance of red meat, animal fat, and processed meats, can go a long way in preventing colon cancer and other GI diseases.
It is known that psychological stress can aggravate symptoms of Crohn’s disease, irritable bowel syndrome, and ulcerative colitis. Taking a mind-body approach to health can help these patients manage their illnesses. Techniques such as yoga, meditation, massage, and acupuncture can lower stress and in turn reduce bowel symptoms. Doctors also recommend an anti-inflammatory diet (omega-3 fatty acids, fruits & vegetables, and protein rich food like fish, chicken and soy) for people suffering from Crohn’s disease.
Gastrointestinal Industry Research & Market Reports
-
2022 Guatemala Virology, Bacteriology, Parasitology and Mycology Market Size, Shares and Forecasts for over 100 Respiratory, STD, Gastrointestinal and Other Tests: Supplier Shares and Strategies, Test Volume and Sales Forecasts through 2026, Latest Technologies, Instrumentation Pipeline, Emerging Opportunities for Analyzers and Reagents
... Pipeline, Emerging Opportunities for Analyzers and Reagents This unique report from LeadingMarketResearch.com provides information not available from any other source , including test volume and sales forecasts for 100 individual tests, and competitor strategies. The ... Read More
-
2022 Latvia Virology, Bacteriology, Parasitology and Mycology Market Size, Shares and Forecasts for over 100 Respiratory, STD, Gastrointestinal and Other Tests: Supplier Shares and Strategies, Test Volume and Sales Forecasts through 2026, Latest Technologies, Instrumentation Pipeline, Emerging Opportunities for Analyzers and Reagents
... Pipeline, Emerging Opportunities for Analyzers and Reagents This unique report from LeadingMarketResearch.com provides information not available from any other source , including test volume and sales forecasts for 100 individual tests, and competitor strategies. The ... Read More
-
2022 New Zealand Virology, Bacteriology, Parasitology and Mycology Market Size, Shares and Forecasts for over 100 Respiratory, STD, Gastrointestinal and Other Tests: Supplier Shares and Strategies, Test Volume and Sales Forecasts through 2026, Latest Technologies, Instrumentation Pipeline, Emerging Opportunities for Analyzers and Reagents
... Instrumentation Pipeline, Emerging Opportunities for Analyzers and Reagents This unique report from LeadingMarketResearch.com provides information not available from any other source , including test volume and sales forecasts for 100 individual tests, and competitor strategies. ... Read More
-
2022 Saudi Arabia Virology, Bacteriology, Parasitology and Mycology Market Size, Shares and Forecasts for over 100 Respiratory, STD, Gastrointestinal and Other Tests: Supplier Shares and Strategies, Test Volume and Sales Forecasts through 2026, Latest Technologies, Instrumentation Pipeline, Emerging Opportunities for Analyzers and Reagents
... Instrumentation Pipeline, Emerging Opportunities for Analyzers and Reagents This unique report from LeadingMarketResearch.com provides information not available from any other source , including test volume and sales forecasts for 100 individual tests, and competitor strategies. ... Read More
-
2022 South Korea Virology, Bacteriology, Parasitology and Mycology Market Size, Shares and Forecasts for over 100 Respiratory, STD, Gastrointestinal and Other Tests: Supplier Shares and Strategies, Test Volume and Sales Forecasts through 2026, Latest Technologies, Instrumentation Pipeline, Emerging Opportunities for Analyzers and Reagents
... Instrumentation Pipeline, Emerging Opportunities for Analyzers and Reagents This unique report from LeadingMarketResearch.com provides information not available from any other source , including test volume and sales forecasts for 100 individual tests, and competitor strategies. ... Read More
-
South Africa Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Country Analysis – by Product (Embolic Agents and Support Devices), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Diseases, Urological & Nephrological Disorders, Gastrointestinal Disorders, and Others), Procedure (Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)), and End User (Hospitals & Clinics, Ambulatory Surgery Centers, and Other End Users)
... and Others), Procedure (Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)), and End User (Hospitals & Clinics, Ambulatory Surgery Centers, and Other End Users) The South Africa ... Read More
-
India Over The Counter (OTC) Drug Market, By Product Type (Cold, Cough & Flu, Vitamins, Minerals & Supplements (VMS), Analgesics, Gastrointestinal Products, Dermatology Products, Others), By Route of Administration (Oral, Parenteral, Topical, Others), By Dosage Form (Tablets, Capsules, Liquids & Solutions, Cream/Lotion/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition, Forecast & Opportunities, 2018-2028F
... Form (Tablets, Capsules, Liquids & Solutions, Cream/Lotion/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition, Forecast & Opportunities, 2018-2028F India Over the Counter (OTC) Drug market stood at USD4666.15 million in ... Read More
-
Diabetic Gastroparesis - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Gastrointestinal Stromal Tumor (GIST) - Market Insight, Epidemiology And Market Forecast - 2032
... as well as the GIST market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan. The GIST market report provides current treatment practices, emerging drugs, and market share ... Read More
-
Human Microbiome Market (Product & Service: Product and Service (Diagnostics/Sequencing); and Application: Gastrointestinal Disorders, Metabolic Disorders, Women's Health Disorders, Skin Disorders, and Others) - India Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... Human Microbiome Market – Scope of Report TMR’s report on the human microbiome market in India studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators ... Read More
-
Clostridioides Difficile Infections (Clostridium Difficile Associated Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Infections - Drugs In Development, 2022, provides an overview of the Clostridioides difficile Infections (Infectious Disease) pipeline landscape. Clostridium difficile infections are caused by Clostridium difficile, often called C. difficile or C. diff, a bacterium ... Read More
-
Ulcerative Colitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Ulcerative Colitis (Gastrointestinal) pipeline landscape. Ulcerative Colitis (Colitis ulcerosa or UC) is a chronic disease mainly of the large intestine or colon and a type of Inflammatory Bowel Disease (IBD). ... Read More
-
Gastroenteritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... overview of the Gastroenteritis (Gastrointestinal) pipeline landscape. Gastroenteritis is an infection of the gut. Symptoms include stomach pain, cramping, fever, nausea, and a headache. Causes of gastroenteritis include contaminated food or water, and contact with ... Read More
-
Digestive Enzyme Supplements Market Size, Share & Trends Analysis Report By Origin (Animal, Plant, Microbial), By Application, By Region, And Segment Forecasts, 2018 - 2025
... reach USD 1.6 billion by 2025, according to a new report published by Grand View Research, Inc. Growing consumer awareness regarding the severity of digestive disorders coupled with the need for good health is expected ... Read More
-
IBD [Ulcerative Colitis & Crohn’s Disease] Treatment Market (Drug Class: TNF Inhibitors, Aminosalicylates, Integrin Antagonists, Corticosteroids, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... Treatment Market – Scope of Report TMR’s report on the global IBD (Ulcerative Colitis & Crohn’s Disease) treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights ... Read More
-
Digestive Health Products Market Size, Share & Trends Analysis Report By Ingredient (Prebiotics, Probiotics, Food Enzymes), By Product (Dairy Products, Bakery & Cereals, Non-alcoholic Beverages), By Region, And Segment Forecasts, 2022 - 2030
... a CAGR of 8.2% from 2022 to 2030. Rising geriatric population, increasing healthcare costs, changing lifestyle, and innovation in formulations of digestive health products are primary factors that have contributed towards market growth. The rising ... Read More
-
Contrast Media/Contrast Agents Market Analysis and Forecast to 2031: By Type (Iodinated Contrast Media, Gadolinium Based Contrast Media, Microbubble Contrast Media, Barium Based Contrast Media), Modality (X-ray/CT, MRI, Ultrasound), Route of Administration (Intravascular Route, Oral Route, Rectal Route, Others), Indication (Cardiovascular Disorders, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, Nephrological Disorders), Application (Radiology, Interventional Radiology, Interventional Cardiology), End Users (Hospitals, Clinics & Ambulatory Surgery Centers, Diagnostic Imaging Centers), and Region
... Route, Rectal Route, Others), Indication (Cardiovascular Disorders, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, Nephrological Disorders), Application (Radiology, Interventional Radiology, Interventional Cardiology), End Users (Hospitals, Clinics & Ambulatory Surgery Centers, Diagnostic Imaging Centers), and Region ... Read More
-
Ulcerative Colitis (UC) - Market Insight, Epidemiology And Market Forecast - 2032
... as well as the UC market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), and Japan. The UC market report provides current treatment practices, emerging drugs, UC market share of ... Read More
-
Gastrointestinal Endoscopic Stricture Management Devices - Market Insights, Competitive Landscape and Market Forecast–2027
... Endoscopic Stricture Management Devices and the historical and forecasted Gastrointestinal Endoscopic Stricture Management Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW. The Gastrointestinal Endoscopic Stricture Management Devices market report provides ... Read More
-
Gastrointestinal Anastomosis - Market Insights, Competitive Landscape and Market Forecast-2027
... Gastrointestinal Anastomosis market trends, globally, which comprises of North America, Europe, APAC, and RoW. The Gastrointestinal Anastomosis market report provides an overview of Gastrointestinal Anastomosis , applications of Gastrointestinal Anastomosis as well as its advantages ... Read More
-
Gastric Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Gastric Ulcers (Gastrointestinal) pipeline landscape. Gastric ulcer is a painful sore or ulcer in the lining of stomach. The most common cause of gastric ulcer is Helicobacter pylori bacterial infection. ... Read More
-
Irritable Bowel Syndrome Treatment Market, by Drug Type (Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, and Others), by Medical Condition (IBS-constipation and IBS-diarrhea), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 The treatment of irritable bowel syndrome majorly revolves around relieving the patient from the symptoms ... Read More
-
2022 Diseases of The Digestive System (K00-K95) Global Market Size & Growth Report with COVID-19 Impact
... growth, and share across 4 global regions, 22 subregions, and 216 countries. Figures are from 2012 through 2021, with forecasts for 2022 and 2026. The historical data utilizes in-depth survey results from companies that sell ... Read More
-
Global Micronutrient Powders Market Size study, By Ingredients (Vitamins, Fibers, Botanicals, Proteins, Amino Acids, Minerals, Omega Fatty Acids, Specialty Carbohydrates), By Application (Bone & Joint Health, Anti-cancer, Energy, Weight Management, Cardiac Health, Immunity, General Health, Diabetes, Gastrointestinal Health), By End User (Infants, Pregnant Women, Geriatric, Adults, Children), By Distribution Channel (Supermarkets Direct to Customers (DTC), Online Stores, Others), and Regional Forecasts 2022-2028
... Diabetes, Gastrointestinal Health), By End User (Infants, Pregnant Women, Geriatric, Adults, Children), By Distribution Channel (Supermarkets Direct to Customers (DTC), Online Stores, Others), and Regional Forecasts 2022-2028Global Micronutrient Powders Market is valued approximately USD XX ... Read More
-
Global Oncology Biosimilars Market Size study, By Indication (Atopic Dermatitis, Postoperative Immunosuppression, Ulcerative Colitis, Psoriasis, Keratoconjunctivitis, Others), By Drug Class (Cyclosporine, Tacrolimus, Pimecrolimus, Others), By Route of Administration (Oral, Topical, Parenteral), By End-Users (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), and Regional Forecasts 2022-2028
... Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), and Regional Forecasts 2022-2028 Global Oncology Biosimilars Market is valued approximately USD XX million in 2021 and is anticipated to grow with ... Read More
Research Assistance
